European Journal of Health Economics, 1618-7598

Journal

  1. 2019
  2. 2018
  3. 2017
  4. 2016
  5. 2015
  6. 2014
  7. 2013
  8. Ramos, G. F. P., van Asselt, A. D. I., Kuiper, S., Severens, J. L., Maas, T., Dompeling, E., ... van Schayck, O. C. P. (2013). Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model. European Journal of Health Economics, 15(8), 869-883. https://doi.org/10.1007/s10198-013-0532-x
  9. 2012
  10. Lenoir-Wijnkoop, I., van Aalderen, W. M. C., Boehm, G., Klaassen, D., Sprikkelman, A. B., & Nuijten, M. J. C. (2012). Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands. European Journal of Health Economics, 13(1), 101-110. https://doi.org/10.1007/s10198-010-0289-4
  11. 2011
  12. 2006
  13. Postma, T. J. B. M., Alers, J., Terpstra, S., & Zuurbier, A. (2006). Delphi-study: The future of imaging techniques for cancer patients in the Netherlands. European Journal of Health Economics, 7(2), 117 - 122.
  14. 2004
  15. Postma, M., Bos, J. M., Welte, R., de Groot, R., Luytjes, W., Römke, H. C., & Beutels, P. H. (2004). Do costs of varicella justify routine infant vaccination? European Journal of Health Economics, 1, 54 - 57. https://doi.org/10.1007/s10198-003-0201-6
  16. 2003
  17. Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., ... de Charro, F. (2003). A single European currency for EQ-5D health states: results from a six-country study. European Journal of Health Economics, 4(3), 222-231. https://doi.org/10.1007/s10198-003-0182-5
  18. 2002

ID: 610018